What amount sold does GT MEDICAL TECHNOLOGIES, INC. report in Form D filings?

The latest linked filings report $164.6M sold across 8 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was GT MEDICAL TECHNOLOGIES, INC.'s most recent SEC filing?

GT MEDICAL TECHNOLOGIES, INC.'s most recent Form D filing was on 2026-07-22.

How many investors does GT MEDICAL TECHNOLOGIES, INC. have?

The most recent Form D filing lists 39 investor(s).

What type of securities does GT MEDICAL TECHNOLOGIES, INC. offer?

GT MEDICAL TECHNOLOGIES, INC.'s SEC Form D filings indicate equity offerings.

GT MEDICAL TECHNOLOGIES, INC.

CIK: 0001723008·Other Health Care·TEMPE, AZ·Corporation

Reported Sold

$164,576,411

Total Filings

Identified Offerings

Last Filed

Jul 22, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Jul 22, 2026Form D — New notice

Reported sold: $50,056,676 · Target: $100,056,698

Rule 506(b)·39 investors

Jun 11, 2025Form D/A — Amendment

Reported sold: $53,300,905 · Target: $53,300,905

Rule 506(b)·37 investors

Changed: Reported amount sold, Offering target, Reported investors

Mar 3, 2025Form D — New notice

Reported sold: $37,100,907 · Target: $43,505,901

Rule 506(b)·16 investors

Apr 30, 2024Form D — New notice

Reported sold: $218,022 · Target: $218,022

Rule 506(b)·1 investor

Mar 24, 2023Form D — New notice

Reported sold: $37,420,783 · Target: $45,137,701

Rule 506(b)·33 investors

Nov 18, 2020Form D — New notice

Reported sold: $15,484,660 · Target: $16,000,026

Rule 506(b)·15 investors

Nov 26, 2018Form D — New notice

Reported sold: $5,641,290 · Target: $10,019,822

Rule 506(b)·30 investors

Jan 5, 2018Form D — New notice

Reported sold: $1,944,075 · Target: $2,200,000

Rule 506(b)·4 investors

Dec 14, 2017Form D — New notice

Reported sold: $510,000 · Target: $750,000

Rule 506(b)·5 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

11%

Latest reported sold across 8 identified offerings

$164,576,411

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Prattipati Laxminarain

Related Person

Appears on 6 filings

David G. Brachman

Related Person

Appears on 6 filings

Kyle Dempsey

Related Person

Appears on 5 filings

Geoff Pardo

Related Person

Appears on 4 filings

Matthew E. Likens

Related Person

Appears on 3 filings

Per Langoe

Related Person

Appears on 3 filings

Radu Cautis

Related Person

Appears on 3 filings

Adam Lessler

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 22, 2026	New	$100,056,698	$50,056,676	39
Jun 11, 2025	Amendment	$53,300,905	$53,300,905	37
Mar 3, 2025	New	$43,505,901	$37,100,907	16
Apr 30, 2024	New	$218,022	$218,022	1
Mar 24, 2023	New	$45,137,701	$37,420,783	33
Nov 18, 2020	New	$16,000,026	$15,484,660	15
Nov 26, 2018	New	$10,019,822	$5,641,290	30
Jan 5, 2018	New	$2,200,000	$1,944,075	4
Dec 14, 2017	New	$750,000	$510,000	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

BRIDGE TO LIFE LTD

Other Health Care

Offering target: $82,500,000

Filed Oct 21, 2026